{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T20:13:32Z","timestamp":1789935212513,"version":"4.0.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.ejphar.2008.04.055","type":"journal-article","created":{"date-parts":[[2008,5,7]],"date-time":"2008-05-07T13:40:04Z","timestamp":1210167604000},"page":"194-200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Comparison of pharmacodynamics between carvedilol and metoprolol in rats with isoproterenol-induced cardiac hypertrophy: Effects of carvedilol enantiomers"],"prefix":"10.1016","volume":"589","author":[{"given":"Kazuhiko","family":"Hanada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Asari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masako","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-ichi","family":"Kawana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuo","family":"Mita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyasu","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.1016\/j.ejphar.2008.04.055_bib1","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1007\/BF01409475","article-title":"Pharmacological characteristics of the stereoisomers of carvedilol","volume":"38","author":"Bartsch","year":"1990","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.04.055_bib2","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1161\/01.CIR.101.5.558","article-title":"\u03b2-adrenergic receptor blockade in chronic heart failure","volume":"101","author":"Bristow","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2008.04.055_bib3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJM198207223070401","article-title":"Decreased catecholamine sensitivity and \u03b2-adrenergic-receptor density in failing human hearts","volume":"307","author":"Bristow","year":"1982","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2008.04.055_bib4","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1161\/01.CIR.94.11.2807","article-title":"Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators","volume":"94","author":"Bristow","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2008.04.055_bib5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0014-2999(02)02643-2","article-title":"Toxic cardiac effects of catecholamines: role of \u03b2-adrenoceptor downregulation","volume":"456","author":"Brouri","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.04.055_bib6","doi-asserted-by":"crossref","first-page":"17223","DOI":"10.1074\/jbc.272.27.17223","article-title":"Mechanism of \u03b2-adrenergic receptor desensitization in cardiac hypertrophy is increased \u03b2-adrenergic receptor kinase","volume":"272","author":"Choi","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2008.04.055_bib7","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0008-6363(00)00277-7","article-title":"Differential effects of carvedilol and metoprolol on isoprenaline-induced changes in \u03b2-adrenoceptor density and systolic function in rat cardiac myocytes","volume":"49","author":"Flesch","year":"2001","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2008.04.055_bib8","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1161\/01.CIR.94.11.2817","article-title":"Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart","volume":"94","author":"Gilbert","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2008.04.055_bib9","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1161\/01.CIR.79.3.483","article-title":"Increased \u03b2-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy","volume":"79","author":"Heilbrunn","year":"1989","journal-title":"Circulation"},{"issue":"Suppl9","key":"10.1016\/j.ejphar.2008.04.055_bib10","doi-asserted-by":"crossref","first-page":"A56","DOI":"10.1016\/j.jacc.2006.07.007","article-title":"Molecular mechanisms in heart failure focus on cardiac hypertrophy, inflammation, angiogenesis, and apoptosis","volume":"48","author":"Hilfiker-Kleiner","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2008.04.055_bib11","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ahj.2003.07.023","article-title":"Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial","volume":"147","author":"Hori","year":"2004","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ejphar.2008.04.055_bib12","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1161\/01.CIR.98.17.1783","article-title":"Reciprocal in vivo regulation of myocardial G protein-coupled receptor kinase expression by \u03b2-adrenergic receptor stimulation and blockade","volume":"98","author":"Iaccarino","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2008.04.055_bib13","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1161\/01.HYP.33.1.396","article-title":"\u0392-adrenergic receptor kinase-1 levels in catecholamine-induced myocardial hypertrophy: regulation by \u03b2- but not alpha1-adrenergic stimulation","volume":"33","author":"Iaccarino","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2008.04.055_bib14","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0735-1097(01)01396-1","article-title":"Regulation of myocardial betaARK1 expression in catecholamine-induced cardiac hypertrophy in transgenic mice overexpressing alpha1B-adrenergic receptors","volume":"38","author":"Iaccarino","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2008.04.055_bib15","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S0002-9149(97)89342-3","article-title":"Combined \u03b1\u2013\u03b2 blockade (doxazosin plus metoprolol) compared with \u03b2 blockade alone in chronic congestive heart failure","volume":"77","author":"Kukin","year":"1996","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ejphar.2008.04.055_bib16","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.cardiores.2005.01.025","article-title":"G-protein-coupled receptor kinase activity in human heart failure: effects of \u03b2-adrenoceptor blockade","volume":"66","author":"Leineweber","year":"2005","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2008.04.055_bib17","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1161\/01.CIR.101.14.1707","article-title":"Early and delayed consequences of \u03b22-adrenergic receptor overexpression in mouse hearts: critical role for expression level","volume":"101","author":"Liggett","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2008.04.055_bib18","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2008.04.055_bib19","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","article-title":"Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2008.04.055_bib20","first-page":"289","article-title":"Ultrastructural and electrophysiological alterations during the development of catecholamine-induced cardiac hypertrophy and failure","volume":"41","author":"Meszaros","year":"1990","journal-title":"Acta Biol. Hung."},{"key":"10.1016\/j.ejphar.2008.04.055_bib21","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1093\/eurheartj\/ehi386","article-title":"Influence of heart rate, blood pressure, and \u03b2-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial","volume":"26","author":"Metra","year":"2005","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejphar.2008.04.055_bib22","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2165\/00003088-199426050-00002","article-title":"Clinical pharmacokinetics and pharmacodynamics of carvedilol","volume":"26","author":"Morgan","year":"1994","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejphar.2008.04.055_bib23","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199605233342101","article-title":"The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group","volume":"334","author":"Packer","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2008.04.055_bib24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(03)13800-7","article-title":"Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomized controlled trial","volume":"362","author":"Poole-Wilson","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2008.04.055_bib25","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0922-4106(89)90051-5","article-title":"Mechanism of noradrenaline-induced heterologous desensitization of adenylate cyclase stimulation in rat heart muscle cells: increase in the level of inhibitory G-protein alpha-subunits","volume":"172","author":"Reithmann","year":"1989","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.04.055_bib26","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/0304-4165(73)90275-4","article-title":"Basal and hormone-stimulated adenylate cyclase in liver plasma membranes: measurement by radioimmunoassay of cyclic AMP","volume":"304","author":"Rosselin","year":"1973","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2008.04.055_bib27","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jchromb.2006.05.018","article-title":"Enantioselective and highly sensitive determination of carvedilol in human plasma and whole blood after administration of the racemate using normal-phase high-performance liquid chromatography","volume":"843","author":"Saito","year":"2006","journal-title":"J. Chromatogr., B, Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.ejphar.2008.04.055_bib28","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1161\/01.CIR.87.2.454","article-title":"Altered expression of \u03b2-adrenergic receptor kinase and \u03b21-adrenergic receptors in the failing human heart","volume":"87","author":"Ungerer","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2008.04.055_bib29","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1161\/01.RES.79.3.455","article-title":"Activation of \u03b2-adrenergic receptor kinase during myocardial ischemia","volume":"79","author":"Ungerer","year":"1996","journal-title":"Circ. Res."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299908004858?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299908004858?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T20:01:44Z","timestamp":1728417704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299908004858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":29,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S0014299908004858"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2008.04.055","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of pharmacodynamics between carvedilol and metoprolol in rats with isoproterenol-induced cardiac hypertrophy: Effects of carvedilol enantiomers","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2008.04.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}